Nomogram construction for predicting survival of patients with non-small cell lung cancer with malignant pleural or pericardial effusion based on SEER analysis of 10,268 patients.

Tian, Tian; Zhang, Pengpeng; Zhong, Fei; Sun, Cuiling; Zhou, Jian; Hu, Wenjun

Tian, Tian; Zhang, Pengpeng; Zhong, Fei; Sun, Cuiling; Zhou, Jian; Hu, Wenjun.

Afiliación

Tian T; Department of Medical Oncology, Fuyang People's Hospital, Fuyang, Anhui 236000, P.R. China.
Zhang P; Medical Imaging Center, Fuyang Second People's Hospital, Fuyang, Anhui 236000, P.R. China.
Zhong F; Department of Medical Oncology, Affiliated Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, P.R. China.
Sun C; Department of Medical Oncology, Fuyang People's Hospital, Fuyang, Anhui 236000, P.R. China.
Zhou J; Department of Medical Oncology, Fuyang People's Hospital, Fuyang, Anhui 236000, P.R. China.
Hu W; Department of Medical Oncology, Fuyang People's Hospital, Fuyang, Anhui 236000, P.R. China.

Oncol Lett ; 19(1): 449-459, 2020 Jan.

Article en En | MEDLINE | ID: mdl-31897158

Palabras clave

malignant pericardial effusion; malignant pleural effusion; non-small cell lung cancer; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2020 Tipo del documento: Article Pais de publicación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google